Article Details

Global $223.21 Billion Oncology Drugs Markets to 2031 with F.Hoffmann-La Roche ... - Benzinga

Retrieved on: 2022-06-21 11:25:15

Tags for this article:

Click the tags to see associated articles and topics

Global $223.21 Billion Oncology Drugs Markets to 2031 with F.Hoffmann-La Roche ... - Benzinga. View article details on HISWAI: https://www.benzinga.com/pressreleases/22/06/g27791195/global-223-21-billion-oncology-drugs-markets-to-2031-with-f-hoffmann-la-roche-novartis-gilead-scie

Excerpt

Hoffmann-La Roche Ltd., Novartis AG, Gilead Sciences Inc., Bayer AG and Takeda Pharmaceuticals. North America was the largest region in the oncology ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up